GDF5 modulation of MuSC pool as a potential therapeutic benefit for DMD
Authors:
- Christel GentilCGChristel Gentil
- Aly BourguibaABAly Bourguiba
- Amélie VergnolAVAmélie Vergnol
- Bruno CadotBCBruno Cadot
- Zoheir GuesmiaZGZoheir Guesmia
- Lucile SaillardLSLucile Saillard
- Pierre MeunierPMPierre Meunier
- Bénédicte Hoareau-CoudertBHBénédicte Hoareau-Coudert
- Sestina FalconeSFSestina Falcone
- Lorenzo GiordaniLGLorenzo Giordani
- France Pietri-RouxelFPFrance Pietri-Rouxel
Preprint
Abstract
Duchenne muscular dystrophy (DMD) is a fatal disease caused by dystrophin deficiency, leading to degeneration of the entire musculature. To improve muscle pathophysiology and gene therapy for DMD, we investigated the potential of growth differentiation factor 5 (GDF5) in the DMD mdx mouse model. We showed that the overexpression of GDF5 in the muscle improved its histology, reduced inflammation, modulated regeneration and induced the appearance of de novo fibers. We demonstrated that muscle satellite cells (MuSCs) are targeted by GDF5 which enhanced their proliferation and slowed down their myogenic commitment and finally their fusion. When combined with AAV-mediated microdystrophin gene therapy, the leading therapeutic strategy, GDF5 further increased the number of microdystrophin-positive fibers compared to gene therapy alone. These findings highlight GDF5 as a promising modulator of DMD pathology and provide the first evidence of a synergistic effect of the combination of GDF5-based intervention and AAV-microdystrophin treatment.Keywords
This publication has 61 references indexed in Scilit:
- MuSCs and IPCs: roles in skeletal muscle homeostasis, aging and injuryCellular and Molecular Life Sciences, 2024
- Regulatory T cells require IL6 receptor alpha signaling to control skeletal muscle function and regenerationCell Metabolism, 2023
- Cell adhesion an important determinant of myogenesis and satellite cell activityBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022
- Cell Detection with Star-Convex Polygons2018
- Niche Cadherins Control the Quiescence-to-Activation Transition in Muscle Stem CellsCell Reports, 2017
- An HMGA2-IGF2BP2 Axis Regulates Myoblast Proliferation and MyogenesisDevelopmental Cell, 2012
- Congenital inflammatory myopathy: A demonstrative case and proposed diagnostic classificationMuscle & Nerve, 2002
- Role of Id family proteins in growth controlJournal of Cellular Physiology, 2001
- Elevated p21 mRNA level in skeletal muscle of DMD patients and mdx mice indicates either an exhausted satellite cell pool or a higher p21 expression in dystrophin-deficient cells per seJournal of Molecular Medicine, 2000
- Fast muscle fibers are preferentially affected in Duchenne muscular dystrophyCell, 1988